Bedfont® Scientific one step closer to improving smoking cessation in Latin America

Bedfont® Scientific Limited, an innovative MedTech company with nearly 50 years of experience in the breath analysis industry, is pleased to collaborate with Medicah S.A.S through a new registration for the Smokerlyzer® range of carbon monoxide (CO) monitoring devices. The partnership aims to improve smoking cessation services across Colombia.

Image Credit: Bedfont® Scientific Ltd

Bedfont® has been helping people to quit smoking with its Smokerlyzer® range for over 40 years. The Smokerlyzer® range measures levels of CO in parts per million (ppm) on exhaled breath, helping to establish a person’s smoking status. Monitoring CO levels and seeing them drop during a quit attempt provides smokers with a motivational aid to quit smoking.

Medicah S.A.S, a distributor of medical technology, supports hospitals, clinics and diagnostic providers through product supply and after-sales service. Already a distributor of the Bedfont® NObreath® Fractional exhaled Nitric Oxide (FeNO) device, Medicah S.A.S. is chosen for its shared commitment to improving patient outcomes, with the Smokerlyzer® range an important addition to its product catalogue.

We are delighted to expand our partnership with Medicah through the registration of our Smokerlyzer® range in Colombia. Having successfully worked together to bring our NObreath® to healthcare professionals across the region, we are proud that this latest addition strengthens Medicah's respiratory diagnostics portfolio and reinforces our shared commitment to improving patient care.”

Jason Smith, CEO, Bedfont®

CO monitoring plays a vital role in smoking cessation programs and respiratory health management, providing clinicians with an objective and immediate measure to support behaviour change and treatment decisions.

Whilst Colombia is considered a relatively low-smoking country in Latin America, the latest registration of the Smokerlyzer® range of CO monitoring devices provides an additional tool, making this technology more widely available, allowing healthcare providers to deliver more effective interventions and improve patient outcomes throughout Colombia and the surrounding areas.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bedfont® Scientific Ltd. (2026, September 09). Bedfont® Scientific one step closer to improving smoking cessation in Latin America. News-Medical. Retrieved on September 09, 2026 from https://www.news-medical.net/news/20260909/Bedfontc2ae-Scientific-one-step-closer-to-improving-smoking-cessation-in-Latin-America.aspx.

  • MLA

    Bedfont® Scientific Ltd. "Bedfont® Scientific one step closer to improving smoking cessation in Latin America". News-Medical. 09 September 2026. <https://www.news-medical.net/news/20260909/Bedfontc2ae-Scientific-one-step-closer-to-improving-smoking-cessation-in-Latin-America.aspx>.

  • Chicago

    Bedfont® Scientific Ltd. "Bedfont® Scientific one step closer to improving smoking cessation in Latin America". News-Medical. https://www.news-medical.net/news/20260909/Bedfontc2ae-Scientific-one-step-closer-to-improving-smoking-cessation-in-Latin-America.aspx. (accessed September 09, 2026).

  • Harvard

    Bedfont® Scientific Ltd. 2026. Bedfont® Scientific one step closer to improving smoking cessation in Latin America. News-Medical, viewed 09 September 2026, https://www.news-medical.net/news/20260909/Bedfontc2ae-Scientific-one-step-closer-to-improving-smoking-cessation-in-Latin-America.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Bedfont® Scientific recognized for global growth with SEHTA Awards export shortlist